Forrester announced the results of its survey of 395 marketers and e-business executives from large companies ranging the U.S., UK and Canada.
"While lots of marketers spend lots of money on Facebook today, relatively few find success," wrote Forrester analyst Nate Elliott in the report.
Shares of Facebook fell $1.47, or nearly 3%, at $50.48 in midday trading.
Forrester's report says that Facebook in particular doesn't give marketers enough ability to drive engagement between companies and customers.
While the world's largest social network is failing marketers, it is also leaning on traditional online advertising that isn't doing well for those advertisers, says the report.
Top 5 Undervalued Stocks To Own For 2015: Zhongpin Inc.(HOGS)
Zhongpin Inc. engages in the processing and distribution of meat and food products primarily in the People?s Republic of China. The company provides pork and pork products, such as chilled pork, frozen pork, hog by-products and variety meats, and prepared meats; and vegetable and fruit products, including asparagus, sweet corn, broccoli, mushrooms, lima beans, strawberries, and capsicums. It sells its products fast food companies, processing factories, school cafeterias, factory canteens, hotels, army bases, and government departments, as well as directly to retail outlets, including supermarkets. The company also exports its products to Europe, Hong Kong, and other countries in Asia. As of December 31, 2010, it operated 157 showcase stores, 1,072 branded stores, and 2,097 supermarket counter locations. The company is headquartered in Changge City, the People?s Republic of China.
Advisors' Opinion:- [By Dan Caplinger]
Obviously, the big news for Smithfield during the quarter came from Shuanghui International's offer to buy out the company for $34 per share. The $4.7 billion offer has raised some nationalistic concerns, as the Committee on Foreign Investment in the U.S. will have to approve the merger, but Smithfield CEO Larry Pope said last month when the deal was announced that it believes the deal won't have an effect on the company's operations. In fact, the combination of China's largest meat processor and the world's biggest pork producer could produce a formidable opponent to industry rivals. In particular, Chinese pork producer Zhongpin (NASDAQ: HOGS ) will inevitably find itself under pressure if the deal goes through, as Shuanghui puts itself in a stronger competitive position in the industry.
Top 10 Prefered Stocks To Watch Right Now: Spherix Inc (SPEX)
Spherix Incorporated (Spherix), incorporated on May 1, 1992, is a scientific research company. The Company is engaged in developing biopharmaceutical products and providing technical and regulatory consulting services to food, consumer products and pharmaceutical companies. The Company operates in two segments: Biospherics Incorporated (Biospherics), the Company's biotechnology research and development business, and Health Sciences, a technical and regulatory consulting business. The Company has created two wholly owned subsidiaries, Biospherics Incorporated and Spherix Consulting, Inc. (Spherix Consulting), for its two operating segments. The Company's Health Sciences contracts are in the name of Spherix Consulting, and the Company's patents are in the name of Biospherics Incorporated. Spherix provides management, strategic guidance, business development, marketing and other services to its subsidiaries. In September 2013, Spherix Incorporated closed on the acquisition of North South Holdings Inc.
Biospherics
The Company focuses its studies on treating high triglycerides and other dyslipidemias with a combination of D-tagatose and SPX-106, a licensed drug compound, which combination is referred to as SPX-106T. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides. Biospherics has also completed a global Phase III clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose, as a treatment for glycemic control in patients with Type 2 diabetes.
Health Sciences
The Company's Health Sciences business provides technical and regulatory consulting services to biotechnology and pharmaceutical companies, as well as providing technical suppo! rt for its research and development activities. During the year ended December 31, 2011, Health Sciences provided services to 20 companies. The projects range from safety analyses of food ingredients to safety analyses of pharmaceutical manufacturing and dispensing equipment. Health Sciences is also monitoring and directing the clinical trials for Biospherics.
Advisors' Opinion:- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Spherix Inc.(SPEX) on Thursday said that it is suing Cisco Inc.(CSCO) (CSCO), a leging that $43 billion in Cisco sales infringed on Spherix patents. Spherix–which described itself as an “intellectual property development company committed to the fostering and monetization of intellectual property”��aid Cisco infringes on 11 patents it acquired in December. Spherix shares rose 4.9% to $4.70 premarket.
- [By Sue Chang and Ben Eisen]
SPEX: Spherix Inc. (SPEX) �shares rose 5% after the intellectual property development company said it had completed a $20 million equity financing that involved selling 10 million shares of convertible preferred stock.
- [By Susan Decker]
In more than two decades as a publicly-traded company, Spherix Inc. (SPEX) developed diabetes treatments, marketed a low-calorie sweetener and handled campground reservations. Now it�� dealing in something completely different: patents.
- [By Paul Ausick]
Big earnings movers: Chinese internet firm Qihoo 360 Technology Co. Ltd. (NYSE: QIHU) is up 8% at $78.99 on strong earnings and a buoyant outlook. A small biotech firm, Spherix Inc. (NASDAQ: SPEX) jumped 26.7% to more than $14 on earnings. On Tuesday we are scheduled to get earnings from LDK Solar Co. Ltd. (NYSE: LDK) and Tiffany & Co. (NYSE: TIF) before markets open. After Tuesday�� close we��l hear from Workday Inc. (NYSE: WDAY) and TiVo Inc. (NASDAQ: TIVO), among others.
Top 10 Prefered Stocks To Watch Right Now: Sucampo Pharmaceuticals Inc (SCMP)
Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�� prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�� products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl).
AMITIZA
The Company�� AMITIZA is being marketed in the United States for three gastrointestinal indications under a license agreement, or the Takeda Agreement, with Takeda Pharmaceutical Company Limited, or Takeda. The three gastrointestinal indications include chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. AMITIZA for OIC received approval from the United States Food and Drug Administration (FDA), in April 2013. In Japan, AMITIZA is marketed under a license, commercialization and supply agreement, or the Abbott Agreement, with Abbott Japan Co. Ltd. (Abbott), for the gastrointestinal indication of chronic constipation (CC), excluding constipation caused by organic diseases. In Switzerland, the Company is marketing AMITIZA.
RESCULA
The Company holds license agreements for RESCULA in the United States and Canada and the rest of the world, with the exception of Japan, Korea, Taiwan and the People�� Republic of China. The Company is commercializing RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% for the lowering of intraocular pressure (IOP), in patients with open-angle glaucoma or ocular hypertension in the United States. RESCULA may be used as an agent or concomit! antly with other topical ophthalmic drug products to lower intraocular pressure. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.
Advisors' Opinion:- [By James Brumley]
Still, for the nimble who know when to get out, OREX is one of the few cheap stocks worth a closer look.
Sucampo Pharmaceuticals (SCMP)Finally, though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve seen SCMP stock suffer since peaking in mid-January. It’s not a pullback that’s bound to go unchallenged by the bulls.
Top 10 Prefered Stocks To Watch Right Now: NuPathe Inc.(PATH)
NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. The company?s advanced product candidate includes Zelrix an active single-use transdermal sumatriptan patch that is used for the treatment of migraine. Its proprietary product candidates in preclinical development stage comprise NP201 for the continuous symptomatic treatment of Parkinson?s disease; and NP202 for the long-term treatment of schizophrenia and bipolar disorder. NuPathe Inc. was founded in 2005 and is headquartered in Conshohocken, Pennsylvania.
Advisors' Opinion:- [By Vanina Egea] lli revealed owning a stake of 1,313,500 NuPathe Inc. shares, worth 0.01% of his portfolio. NuPathe Inc. has a market cap of $142 million; its shares are trading currently at around $4.3 with a P/B ratio of 18.4.
NuPathe is a specialty pharmaceutical company, focusing on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. Teva Pharmaceutical Industries Ltd. (TEVA) announced a tender offer for all of the outstanding shares of common stock at a price of $3.65 per share in cash, and NuPathe stockholders will receive rights to receive additional cash payments of up to $3.15 per share The firm will become a wholly owned subsidiary of Teva, and common stock will cease to be traded on the Nasdaq following completion of the merger.
Hedge fund gurus have also been active in the company: Jim Simons (Trades, Portfolio) and Ronald Muhlenkamp (Trades, Portfolio) have invested in it.
ATMI Inc. (ATMI)
Gabelli reported a stake of 1,193,900 shares of ATMI Inc., sized at 0.22% of his portfolio, and 3.75% of the company. It has a market cap of $1.08 billion; its shares are trading at $34.04 with a P/E ratio of 28.6 and P/S ratio of 2.77.
ATMI supplies high performance materials, materials packaging and materials delivery systems for use in the manufacture of microelectronics devices worldwide. ATMI agreed to be acquired by Entegris (ENTG) for $1.15 billion, or $34 per share. The deal will provide a lot more of product offerings. The acquisition is expected to close during the second calendar quarter of 2014.
Hedge fund gurus have also been active in the company. Jim Simons (Trades, Portfolio), Arnold Schneider (Trades, Portfolio) and Paul Tudor Jones (Trades, Portfolio) have divested in it in the last quarter.
Nobility Homes Inc. (NOBH)
Finally, Gabelli reported owning 234.950 shares of Nobility Homes, sized at 5.97% of the company�� shares outstanding and 0.01% of Gabelli�
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are Delta Air Lines Inc.(DAL), NuPathe Inc.(PATH) and YRC Worldwide Inc.(YRCW)
Top 10 Prefered Stocks To Watch Right Now: DST Systems Inc. (DST)
DST Systems, Inc. provides information processing and software services and products. The company operates in two segments, Financial Services and Customer Communications. The Financial Services segment offers various solutions primarily to the asset management, brokerage, retirement, insurance, and healthcare industries. It provides proprietary software systems, including shareowner recordkeeping and distribution support systems for the United States and international mutual fund companies, broker/dealers, and financial advisors; and a defined-contribution participant recordkeeping system for the United States retirement plan market. This segment also offers investment management systems for the United States and international investment managers and fund accountants; a business process management and customer contact system for various industries; and medical and pharmacy claims administration processing systems and services for providers of healthcare plans, third party administrators, medical practice groups, and pharmacy benefit managers. The Customer Communications Segment helps businesses deploy customer communications while improving operational performance across critical business functions, such as sales, marketing, customer service, technology, finance, operations, and compliance. This segment helps clients deliver information in the desired combination of print, digital, and archival formats. Its product offering combines data insights and analysis with business decision-making tools, and multi-channel execution and delivery designed to help businesses acquire, grow, retain, and win back customers. The company also owns and operates real estate properties, as well as has investments in equity securities, private equity funds, and other financial interests. It has operations in the United States, the United Kingdom, Canada, Australia, and internationally. DST Systems, Inc. was founded in 1968 and is based in Kansas City, Missouri.< /p> Advisors' Opinion:
- [By Vera Yuan]
��nformation processing company DST Systems, Inc. (DST) declined as the company conducted a secondary offering of common stock for a selling shareholder, Argyros Group.
- [By Rich Duprey]
Data center operator DST Systems (NYSE: DST ) will pay a second-quarter dividend of $0.30 per share, the same rate it paid last quarter after switching from a semiannual payout schedule to a quarterly one, the company announced yesterday.
Top 10 Prefered Stocks To Watch Right Now: Equity Lifestyle Properties Inc. (ELS)
Equity LifeStyle Properties, Inc. is a publicly owned real estate investment trust (REIT). The firm engages in the ownership and operation of lifestyle oriented properties. Its portfolio of properties include various amenities and common facilities, such as a clubhouse, a swimming pool, laundry facilities, and cable television service, sauna/whirlpool spas, golf courses, tennis, shuffleboard and basketball courts, and exercise rooms. The firm leases developed sites to owners of manufactured homes referred to as resort homes, park models referred to as resort cottages, and recreational vehicles. It primarily invests in the markets of the United States. The firm primarily invests in land with lower maintenance costs and customer turnover costs, high quality real estate in and around major metropolitan areas, high barriers to entry, retirement and vacation destinations, growth markets, and appreciating component of real estate2. It was formerly known as Home Communities, Inc. The firm was founded in 1992 and is based in Chicago, Illinois with additional offices in Clearwater, Florida, Phoenix, Arizona, and Aurora, Colorado.
Advisors' Opinion:- [By Lawrence Meyers]
I�� talking about manufactured home communities. In the case of Equity LifeStyle Properties (ELS), 70% are communities for those 55 years of age or older. It�� a great niche, and this REIT has grown into 370 communities and resorts in 32 states and British Columbia, which contain 140,000 actual sites. The properties certainly look nice on the company�� home page, and community living for seniors has taken on increased popularity over the past twenty years.
- [By John Udovich]
Trailer parks may have a bad reputation, but Yahoo! Finance�� Breakout segment was recently touting trailer parks as a hot new investment area���meaning its time for retail investors who don�� want to invest in physical parks to start taking a closer look at trailer park stocks Equity Lifestyle Properties, Inc (NYSE: ELS), Sun Communities Inc (NYSE: SUI) and UMH Properties, Inc (NYSE: UMH). According to the segment, roughly 6% of Americans lived in trailer homes as of 2012 with the�supply of designated trailer parks being quite low because no one wants one in their backyard. Anthony Effinger, the author of another article about trailer parks for Bloomberg, was quoted as saying:
- [By Rich Duprey]
Real estate investment trust Equity Lifestyle Properties (NYSE: ELS ) announced yesterday�that it's splitting its stock 2-for-1 on July 15 for holders of record on July 5.�
Top 10 Prefered Stocks To Watch Right Now: International Stem Cell Corp (ISCO)
International Stem Cell Corporation, incorporated on June 7, 2005 is a developmental-stage biotechnology company. The Company focused on therapeutic and biomedical product development. The Company�� wholly owned subsidiary Lifeline Cell Technology, LLC (LCT) develops, manufactures and commercializes over 130 human cell culture products, including frozen human primary cells and the reagents (media) needed to grow, maintain and differentiate the cells, in order to address this market opportunity. The Company�� scientists have used a technology called basal medium optimization to systematically produce optimized products designed to culture specific human cell types and to elicit specific cellular behaviors. The Company�� wholly owned subsidiary Lifeline Skin Care, Inc. (LSC) develops, manufactures and markets cosmetic skin care products using an extract derived from its pluripotent stem cells.
Therapeutic Product Candidates
Using the Company's technologies and know-how, the Company is exploring and creating a range of cell types that is useful in therapeutic treatments, which include Liver cells (hepatocytes) that may be used to treat a range of congenital and acquired liver diseases. Neuronal cells for potential treatment of Parkinson's disease and other central nervous system disorders, such as traumatic brain injury, stroke and Alzheimer�� disease. Three-dimensional eye structures to treat degenerative retinal diseases, corneal blindness, and to accelerate corneal healing.
Skin Care Products
The Company�� research scientists developed two skin care products, Defensive Day Serum and Recovery Night Serum, using an extract derived from human parthenogenic stem cells. Defensive Serum contains sunscreen, along with stem cell-derived ingredients. The day serum not only protects the skin from the aging effects of harsh light, but it continues to nurture the skin�� collagen and fibroblasts to give noticeably firmer, smoother, younger-looking ! skin. The Recovery Night Serum is a nighttime therapy that complements the Defensive Day Serum. The night serum nurtures the skin�� collagen and elastin and contains ingredients to defend against damaging free radicals, to help build firmer, smoother, younger and healthier-looking skin.
Research Products
The Company�� Lifeline subsidiary produces and sells over 250 human cell culture products. These products include frozen human cells and stem cells and the reagents needed to grow, maintain and differentiate the cells. These human cell-based products are used domestically and internationally by research scientists in pharmaceutical, academic and government research organizations to study human disease and basic cell biology.
The Company competes with Genzyme Corporation, StemCell, Advanced Cell Technology Inc., Aastrom Biosciences, ViaCyte, Obagi, SkinCeuticals, SkinMedica, Murad, Lonza, Chemicon, Life Technologies, StemCell Technologies, Merck, BioTime and Specialty Media.
Advisors' Opinion:- [By John Udovich]
The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR),�International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23%�view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding�human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.
- [By Peter Graham]
Small cap stocks Greenfield Farms Food Inc (OTCMKTS: GRAS), International Stem Cell Corp (OTCMKTS: ISCO) and Redpoint Bio Corporation (OTCMKTS: RPBC) have all been getting some extra attention lately in various investment newsletters. However, none of these small cap stocks appear to have been the subject or paid promotions or investor relations activities. So does that make any of them good bets for traders and investors alike? Here is a quick look and a reality check:
- [By John Udovich]
From stem cell burgers to earnings reports, the stem cell industry and small cap players in it like NeoStem Inc (NASDAQ: NBS), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been producing some news lately that has probably been overlooked by investors and traders alike given its August. Nevertheless, you might want to pay attention to the following stem cell news:
- [By John Udovich]
Summer and the slow news for the market that usually comes with it�is over with and both stem cell researchers or small� cap stem cell stocks like Advanced Cell Technology, Inc (OTCBB: ACTC), Neuralstem, Inc (NYSEMKT: CUR), NeoStem Inc (NASDAQ: NBS), International Stem Cell Corp (OTCMKTS: ISCO)�and BioRestorative Therapies (OTCBB: BRTX) having news for investors and traders alike. Consider the following:
No comments:
Post a Comment